OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
Simone Bido, Federico N. Soria, Rebecca Z. Fan, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 686

Mitochondria as a therapeutic target for common pathologies
Michael P. Murphy, Richard C. Hartley
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 865-886
Closed Access | Times Cited: 662

Mitochondrial dynamics in health and disease: mechanisms and potential targets
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 407

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Afzal Misrani, Sidra Tabassum, Li Yang
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 400

Defective mitophagy in Alzheimer’s disease
Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy
Ageing Research Reviews (2020) Vol. 64, pp. 101191-101191
Open Access | Times Cited: 262

Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Ahmad Elkouzi, Vinata Vedam‐Mai, Robert S. Eisinger, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 4, pp. 204-223
Open Access | Times Cited: 256

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Qian Cai, Yu Young Jeong
Cells (2020) Vol. 9, Iss. 1, pp. 150-150
Open Access | Times Cited: 205

Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
Ruby I. MacDonald, Katy Barnes, Christopher Hastings, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 4, pp. 891-909
Open Access | Times Cited: 191

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178

Mitochondrial dynamics and their potential as a therapeutic target
B. N. Whitley, E.A. Engelhart, Suzanne Hoppins
Mitochondrion (2019) Vol. 49, pp. 269-283
Open Access | Times Cited: 176

Mitochondrial dynamics and transport in Alzheimer's disease
Padraig J. Flannery, Eugenia Trushina
Molecular and Cellular Neuroscience (2019) Vol. 98, pp. 109-120
Open Access | Times Cited: 165

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 109

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 95

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 84

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
Sen Yang, Jung Hyun Park, Hui‐Chen Lu
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 49

Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
Sadegh Moradi Vastegani, Ava Nasrolahi, Shahab Ghaderi, et al.
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2285-2308
Closed Access | Times Cited: 48

Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7952-7952
Open Access | Times Cited: 23

The interplay between mitochondrial dynamics and autophagy: From a key homeostatic mechanism to a driver of pathology
Alice Lacombe, Luca Scorrano
Seminars in Cell and Developmental Biology (2024) Vol. 161-162, pp. 1-19
Open Access | Times Cited: 21

Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 18

Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies
Kai Meng, Hongyun Jia, Xiaoqing Hou, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 327-327
Open Access | Times Cited: 2

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
Darryll Oliver, P. Hemachandra Reddy
Cells (2019) Vol. 8, Iss. 9, pp. 961-961
Open Access | Times Cited: 146

Andrographolide alleviates Parkinsonism in MPTP‐PD mice via targeting mitochondrial fission mediated by dynamin‐related protein 1
Ji Geng, Wen Liu, Jian Gao, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 23, pp. 4574-4591
Open Access | Times Cited: 102

Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson’s disease
Sitong Feng, Zhen‐Zhen Wang, Yu‐He Yuan, et al.
Pharmacological Research (2019) Vol. 151, pp. 104553-104553
Closed Access | Times Cited: 100

A Self-Assembled α-Synuclein Nanoscavenger for Parkinson’s Disease
Jingyi Liu, Chao Liu, Jinfeng Zhang, et al.
ACS Nano (2020) Vol. 14, Iss. 2, pp. 1533-1549
Closed Access | Times Cited: 86

Page 1 - Next Page

Scroll to top